DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20174627

Comparative evaluation of test characteristics of acetic acid, lugol’s iodine and toluidine blue stains in cervical cancer screening

Ankita Kumari, Neha Singh, Shaila Mitra, Reena Srivastav

Abstract


Background: Cervical cancer rank second in female cancer and India alone account for one fourth of the global cervical cancer burden. The study was aimed to evaluate the diagnostic efficacy of acetic acid (3%), lugol’s iodine and toluidine blue (1%) in detection of abnormal cervical lesions.

Methods: This cross-sectional study was conducted in the Department of Obstetrics and Gynecology, BRD Medical College, Gorakhpur over a period of one year from July 2016 to June 2017. The study included 200 women in age group 20-60 years with signs and symptoms suspicious of abnormal cervical lesion. The cases were subjected to detailed history, clinical examination, Pap smear, Visual inspection test, colposcopy followed by cervical biopsy.

Results: Out of total 200 patients, 114 patients had acetowhite area on VIA (visual inspection with acetic acid) test, 113 were VILI (visual inspection with lugol’s iodine) positive and 107 women stained positive with Toluidine blue but only 88 showed biopsy proven pre-invasive and invasive lesions. So, sensitivity of acetic acid, lugol’s iodine and Toluidine blue was 81.8%, 84.09% and 90.9% respectively. Similarly, the specificity of the three stains were 62.5%, 65.17% and 75.8% respectively.

Conclusions: Toluidine blue (1%) has proved to be significantly more sensitive and specific stain as compared to acetic acid (3%) and lugol’s iodine (50% dilution) in diagnosing pre-invasive and invasive cervical cancer. Hence, it may aid as an important tool in screening and treating precancerous and cancerous lesions.


Keywords


Abnormal cervical lesions, Colposcopy, Invasive cervical cancer, Precancerous lesions, Visual inspection test

Full Text:

PDF

References


WHO, ICO information center on HPV and cervical cancer. Summary report Apr. 2017. Available at www.hpcenter.net.

Satija A. Cervical cancer in India. South Asia centre for chronic disease. Available at http://sancd.org/uploads/pdf/cervical_cancer.pdf. Accessed on February16, 2014.

Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, Ferlay J. Worldwide burden of cervical cancer. Ann Oncol. 2011;22:2675-86.

Yeole BB, Kumar AV, Kurkureet A, Sunny L. Population-based survival from cancers of breast, cervix and ovary in women in Mumbai. Asian Pac J Cancer Prev. 2004;5:308-315.

Shastri SS, Dinshaw K, Amin G, Goswami S, PatilS, Chinoy R, et al. Concurrent evaluation of visual, cytological and HPV testing as screening methods for early detection of cervical neoplasia in Mumbai, India. Bull World Health Organ. 2005;83:186-94.

Sankanarayanan R, Wesley R, Thara S, Dhakad N, Chandralekha B, Sebastian P et al. Test characteristics of visual inspection with 4% acetic acid(VIA) and lugol’s iodine(VILI) in cervical cancer screening in Kerela India. Int J Cancer 2003;106:404-8.

Martin IC, Kerawala CJ, Reed M. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:444-6.

Dinshaw KA, Shastri SS. Screening for cervical cancer in India. Natl Med J India. 2001;14:1-3.

Luthra UK, Prabhakar AK, Seth P, Agarwal SS, Murthy NS, Bhatnagar P, et al. Natural history of precancerous and early cancerous lesions of the uterine cervix. Acta Cytol. 1987;31:226-34.

Bhatla N, Mukhopadhyay A, Joshi S, Kumar A, Kriplani A, Pandey RM, et al. Visual inspection for cervical cancer screening: evaluation by doctor versus paramedical worker. Ind J Cancer. 2004;41(1):32-6.

Satyanarayana L, Asthana S, Bhambani S, Sodhani P, Gupta S. A comparative study of cervical cancer screening methods in a rural community setting of North India. Indian J Cancer. 2014;51:124-8.

Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol. 1995;141:680-9.

Sankarnarayanan R, Rajkumar R, Arrossi S, Theresa R, Esmy PO, Mahé C, et al. Determinants of participation of women in a cervical cancer visual screening trial in rural south India. Cancer Detection Prev. 2003;27(6);457-65.

Epstien JB, Scully C, Spinelli J. Toluidine blue and Lugol’s iodine application in assessment of oral malignant and lesion at risk of malignancy. J Oral Pathol Med. 1992;21(4):160-3.

Singh S, Chandra M, Singh R. Efficacy of three available staining modalities in diagnosing abnormal lesions of cervix. Asian J Obstet Gynecol Practice. 2011;3:18-20.